There is tremendous excitement around the concept of precision oncology–that is, delivering therapies targeted to an individual patient’s specific type of cancer.
But how many patients will truly benefit from these treatments? And do the results for these patients justify the hype? In this episode, we cut through the hype to get precise about the promise of precision medicine. We're joined by Dr. Vinay Prasad, a Hematologist-Oncologist; Associate Professor of Medicine, University of California San Francisco; and best-selling author of Malignant: How Bad Policy and Bad Evidence Harm People with Cancer.
